Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (26)

2023

  1. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

2022

  1. Identification of a shared genetic risk locus for Kawasaki disease and immunoglobulin A vasculitis by a cross-phenotype meta-analysis

    Rheumatology (Oxford, England), Vol. 61, Núm. 3, pp. 1204-1210

  2. IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms

    Journal of Clinical Medicine, Vol. 11, Núm. 19

  3. Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype

    Clinical and experimental rheumatology, Vol. 40, Núm. 4, pp. 727-733

2021

  1. Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals

    Arthritis Research and Therapy

  2. HLA association with the susceptibility to anti-synthetase syndrome

    Joint Bone Spine, Vol. 88, Núm. 3

  3. Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis

    Scientific Reports, Vol. 11, Núm. 1

2019

  1. Leveraging Genetic Findings for Precision Medicine in Vasculitis

    Frontiers in immunology, Vol. 10, pp. 1796

2018

  1. A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility

    PLoS ONE, Vol. 13, Núm. 12

2017

  1. A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294

  2. New insights into the genetic component of non-infectious uveitis through an Immunochip strategy

    Journal of Medical Genetics, Vol. 54, Núm. 1, pp. 38-46

2016

  1. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition

    Clinical and Experimental Rheumatology

2015

  1. Association of HLA-B*41:02 with Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  2. Brief report: Association of HLA-DRB101 with IgA vasculitis (henoch-schönlein)

    Arthritis and Rheumatology, Vol. 67, Núm. 3, pp. 823-827

  3. Specific association of IL17A genetic variants with panuveitis

    British Journal of Ophthalmology, Vol. 99, Núm. 4, pp. 566-570

  4. Study of association of CTLA4 gene variants to non-anterior uveitis

    Tissue Antigens, Vol. 86, Núm. 5, pp. 373-376

2014

  1. A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA

    PLoS ONE, Vol. 9, Núm. 11

  2. Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82

  3. Genetic aspects of vasculitis

    The Vasculitides (Nova Science Publishers, Inc.), pp. 95-120

  4. Influence of the IL17A locus in giant cell arteritis susceptibility

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745